NCT00652665View on ClinicalTrials.gov

Bioavailability Study of Leflunomide Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions
To Determine the Bioequivalence Study Under Fasting
Interventions
DRUG

Leflunomide

Tablets, 20mg, single-dose

DRUG

ARAVA

Tablets, 20mg,single-dose

Sponsors
All Listed Sponsors
collaborator

Novum Pharmaceutical Research Services

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY